Explore the vast range of titles available.

Artificial intelligence (AI) is gaining increasing importance in many medical specialties, yet data on patients' opinions on the use of AI in medicine are scarce. This study aimed to investigate patients' opinions on the use of AI in different aspects of the medical workflow and the level of control and supervision under which they would deem the application of AI in medicine acceptable. Patients scheduled for computed tomography or magnetic resonance imaging voluntarily participated in an anonymized questionnaire between February 10, 2020, and May 24, 2020. Patient information, confidence in physicians vs AI in different clinical tasks, opinions on the control of AI, preference in cases of disagreement between AI and physicians, and acceptance of the use of AI for diagnosing and treating diseases of different severity were recorded. In total, 229 patients participated. Patients favored physicians over AI for all clinical tasks except for treatment planning based on current scientific evidence. In case of disagreement between physicians and AI regarding diagnosis and treatment planning, most patients preferred the physician's opinion to AI (96.2% [153/159] vs 3.8% [6/159] and 94.8% [146/154] vs 5.2% [8/154], respectively; P=.001). AI supervised by a physician was considered more acceptable than AI without physician supervision at diagnosis (confidence rating 3.90 [SD 1.20] vs 1.64 [SD 1.03], respectively; P=.001) and therapy (3.77 [SD 1.18] vs 1.57 [SD 0.96], respectively; P=.001). Patients favored physicians over AI in most clinical tasks and strongly preferred an application of AI with physician supervision. However, patients acknowledged that AI could help physicians integrate the most recent scientific evidence into medical care. Application of AI in medicine should be disclosed and controlled to protect patient interests and meet ethical standards.

ObjectivesTo evaluate the correlation between simple planimetric measurements in axial computed tomography (CT) slices and measurements of patient body composition and anthropometric data performed with bioelectrical impedance analysis (BIA) and metric clinical assessments.MethodsIn this prospective cross-sectional study, we analyzed data of a cohort of 62 consecutive, untreated adult patients with advanced malignant melanoma who underwent concurrent BIA assessments at their radiologic baseline staging by CT between July 2016 and October 2017. To assess muscle and adipose tissue mass, we analyzed the areas of the paraspinal muscles as well as the cross-sectional total patient area in a single CT slice at the height of the third lumbar vertebra. These measurements were subsequently correlated with anthropometric (body weight) and body composition parameters derived from BIA (muscle mass, fat mass, fat-free mass, and visceral fat mass). Linear regression models were built to allow for estimation of each parameter based on CT measurements.ResultsLinear regression models allowed for accurate prediction of patient body weight (adjusted R2 = 0.886), absolute muscle mass (adjusted R2 = 0.866), fat-free mass (adjusted R2 = 0.855), and total as well as visceral fat mass (adjusted R2 = 0.887 and 0.839, respectively).ConclusionsOur data suggest that patient body composition can accurately and quantitatively be determined by using simple measurements in a single axial CT slice. This could be useful in various medical and scientific settings, where the knowledge of the patient’s anthropometric parameters is not immediately or easily available.Key Points• Easy to perform measurements on a single CT slice highly correlate with clinically valuable parameters of body composition.• Body composition data were acquired using bioelectrical impedance analysis to correlate CT measurements with a non-imaging-based method, which is frequently lacking in previous studies.• The obtained equations facilitate a quick, opportunistic assessment of relevant parameters of body composition.

Introduction Deep learning-based algorithms have demonstrated enormous performance in segmentation of medical images. We collected a dataset of multiparametric MRI and contour data acquired for use in radiosurgery, to evaluate the performance of deep convolutional neural networks (DCNN) in automatic segmentation of brain metastases (BM). Methods A conventional U-Net (cU-Net), a modified U-Net (moU-Net) and a U-Net trained only on BM smaller than 0.4 ml (sU-Net) were implemented. Performance was assessed on a separate test set employing sensitivity, specificity, average false positive rate (AFPR), the dice similarity coefficient (DSC), Bland-Altman analysis and the concordance correlation coefficient (CCC). Results A dataset of 509 patients (1223 BM) was split into a training set (469 pts) and a test set (40 pts). A combination of all trained networks was the most sensitive (0.82) while maintaining a specificity 0.83. The same model achieved a sensitivity of 0.97 and a specificity of 0.94 when considering only lesions larger than 0.06 ml (75% of all lesions). Type of primary cancer had no significant influence on the mean DSC per lesion ( p  = 0.60). Agreement between manually and automatically assessed tumor volumes as quantified by a CCC of 0.87 (95% CI, 0.77–0.93), was excellent. Conclusion Using a dataset which properly captured the variation in imaging appearance observed in clinical practice, we were able to conclude that DCNNs reach clinically relevant performance for most lesions. Clinical applicability is currently limited by the size of the target lesion. Further studies should address if small targets are accurately represented in the test data.

ObjectivesThis study compares reduction of strong metal artifacts from large dental implants/bridges using spectral detector CT-derived virtual monoenergetic images (VMI), metal artifact reduction algorithms/reconstructions (MAR), and a combination of both methods (VMIMAR) to conventional CT images (CI).MethodsForty-one spectral detector CT (SDCT) datasets of patients that obtained additional MAR reconstructions due to strongest artifacts from large oral implants were included. CI, VMI, MAR, and VMIMAR ranging from 70 to 200 keV (10 keV increment) were reconstructed. Objective image analyses were performed ROI-based by measurement of attenuation (HU) and standard deviation in most pronounced hypo-/hyperdense artifacts as well as artifact impaired soft tissue (mouth floor/soft palate). Extent of artifact reduction, diagnostic assessment of soft tissue, and appearance of new artifacts were rated visually by two radiologists.ResultsThe hypo-/hyperattenuating artifacts showed an increase and decrease of HU values in MAR and VMIMAR (CI/MAR/VMIMAR-200keV: − 369.8 ± 239.6/− 37.3 ± 109.6/− 46.2 ± 71.0 HU, p < 0.001 and 274.8 ± 170.2/51.3 ± 150.8/36.6 ± 56.0, p < 0.001, respectively). Higher keV values in hyperdense artifacts allowed for additional artifact reduction; however, this trend was not significant. Artifacts in soft tissue were reduced significantly by MAR and VMIMAR. Visually, high-keV VMI, MAR, and VMIMAR reduced artifacts and improved diagnostic assessment of soft tissue. Overcorrection/new artifacts were reported that mostly did not hamper diagnostic assessment. Overall interrater agreement was excellent (ICC = 0.85).ConclusionsIn the presence of strong artifacts due to large oral implants, MAR is a powerful mean for artifact reduction. For hyperdense artifacts, MAR should be supplemented by VMI ranging from 140 to 200 keV. This combination yields optimal artifact reduction and improves the diagnostic image assessment in imaging of the head and neck.Key Points• Large oral implants can cause strong artifacts.• MAR is a powerful tool for artifact reduction considering such strong artifacts.• Hyperdense artifact reduction is supplemented by VMI of 140–200 keV from SDCT.

Objectives Dual-energy computed tomography allows for an accurate and reliable quantification of iodine. However, data on physiological distribution of iodine concentration (IC) is still sparse. This study aims to establish guidance for IC in abdominal organs and important anatomical landmarks using a large cohort of individuals without radiological tumor burden. Methods Five hundred seventy-one oncologic, portal venous phase dual-layer spectral detector CT studies of the chest and abdomen without tumor burden at time point of imaging confirmed by > 3-month follow-up were included. ROI were placed in parenchymatous organs ( n = 25), lymph nodes ( n = 6), and vessels ( n = 3) with a minimum of two measurements per landmark. ROI were placed on conventional images and pasted to iodine maps to retrieve absolute IC. Normalization to the abdominal aorta was conducted to obtain iodine perfusion ratios. Bivariate regression analysis, t tests, and ANOVA with Tukey-Kramer post hoc test were used for statistical analysis. Results Absolute IC showed a broad scatter and varied with body mass index, between different age groups and between the sexes in parenchymatous organs, lymph nodes, and vessels (range 0.0 ± 0.0 mg/ml–6.6 ± 1.3 mg/ml). Unlike absolute IC, iodine perfusion ratios did not show dependency on body mass index; however, significant differences between the sexes and age groups persisted, showing a tendency towards decreased perfusion ratios in elderly patients (e.g., liver 18–44 years/≥ 64 years: 0.50 ± 0.11/0.43 ± 0.10, p ≤ 0.05). Conclusions Distribution of IC obtained from a large-scale cohort is provided. As significant differences between sexes and age groups were found, this should be taken into account when obtaining quantitative iodine concentrations and applying iodine thresholds. Key Points • Absolute iodine concentration showed a broad variation and differed between body mass index, age groups, and between the sexes in parenchymatous organs, lymph nodes, and vessels. • The iodine perfusion ratios did not show dependency on body mass index while significant differences between sexes and age groups persisted. • Provided guidance values may serve as reference when aiming to differentiate healthy and abnormal tissue based on iodine perfusion ratios.

Objectives To evaluate the reduction of artifacts from cardiac implantable electronic devices (CIEDs) by virtual monoenergetic images (VMI), metal artifact reduction (MAR) algorithms, and their combination (VMI MAR ) derived from spectral detector CT (SDCT) of the chest compared to conventional CT images (CI). Methods In this retrospective study, we included 34 patients (mean age 74.6 ± 8.6 years), who underwent a SDCT of the chest and had a CIED in place. CI, MAR, VMI, and VMI MAR (10 keV increment, range: 100–200 keV) were reconstructed. Mean and standard deviation of attenuation (HU) among hypo- and hyperdense artifacts adjacent to CIED generator and leads were determined using ROIs. Two radiologists qualitatively evaluated artifact reduction and diagnostic assessment of adjacent tissue. Results Compared to CI, MAR and VMI MAR ≥ 100 keV significantly increased attenuation in hypodense and significantly decreased attenuation in hyperdense artifacts at CIED generator and leads ( p < 0.05). VMI ≥ 100 keV alone only significantly decreased hyperdense artifacts at the generator ( p < 0.05). Qualitatively, VMI ≥ 100 keV, MAR, and VMI MAR ≥ 100 keV provided significant reduction of hyper- and hypodense artifacts resulting from the generator and improved diagnostic assessment of surrounding structures ( p < 0.05). Diagnostic assessment of structures adjoining to the leads was only improved by MAR and VMI MAR 100 keV ( p < 0.05), whereas keV values ≥ 140 with and without MAR significantly worsened diagnostic assessment ( p < 0.05). Conclusions The combination of VMI and MAR as well as MAR as a standalone approach provides effective reduction of artifacts from CIEDs. Still, higher keV values should be applied with caution due to a loss of soft tissue and vessel contrast along the leads. Key Points • The combination of VMI and MAR as well as MAR as a standalone approach enables effective reduction of artifacts from CIEDs. • Higher keV values of both VMI and VMI MAR at CIED leads should be applied with caution since diagnostic assessment can be hampered by a loss of soft tissue and vessel contrast. • Recommended keV values for CIED generators are between 140 and 200 keV and for leads around 100 keV.

Objectives To investigate inter-scan and inter-scanner variation of iodine concentration (IC) and attenuation in virtual monoenergetic images at 65 keV (HU 65keV ) in patients with repeated abdominal examinations on dual-source (dsDECT), rapid kV switching (rsDECT), and dual-layer detector DECT (dlDECT). Methods We retrospectively included 131 patients who underwent two abdominal DECT examinations on the same scanner (dsDECT: n = 46, rsDECT: n = 45, dlDECT: n = 40). IC and HU 65keV were measured by placing regions of interest in the liver, spleen, kidneys, aorta, portal vein, and inferior vena cava. Overall IC and HU 65keV for each scanner, their inter-scan differences and proportional variation were calculated and compared between scanner types. Results The three scanner-specific cohorts showed similar weight, body diameter, age, sex, and contrast media injection parameters as well as inter-scan differences hereof ( p range: 0.23–0.99). Absolute inter-scan differences of HU 65keV and IC were comparable between scanners ( p range: 0.08–1.0). Overall inter-scan variation was significantly higher in IC than HU 65keV ( p < 0.05). For the liver, rsDECT showed significantly lower inter-scan variation of IC compared to dsDECT/dlDECT ( p = 0.005/0.01), while for the spleen, this difference was only significant compared to dsDECT ( p = 0.015). Normalizing IC of the liver to the portal vein and of the spleen to the aorta did not significantly reduce inter-scan variation ( p = 0.97 and 0.50). Conclusions Iodine measurements across different DECT scanners show inter-scan variation which is higher compared to variation of attenuation values. Inter-scanner differences in longitudinal variation and overall iodine concentration depend on the scanner pairs and organs assessed and should be acknowledged in clinical and scientific DECT applications. Key Points • All scanner types showed comparable inter-scan variation of attenuation, while for iodine, the rapid kV switching DECT showed lower variability in the liver and spleen. • Iodine concentration showed higher inter-scan variation than attenuation measurements; normalization to vessels did not significantly improve inter-scan reproducibility of iodine concentration in parenchymal organs. • Differences between the three scanner types regarding overall iodine concentration and attenuation obtained from both timepoints were within the range of average intra-patient, inter-scan differences for most assessed organs and vessels.

Dual-energy CT allows for the reconstruction of virtual non-contrast (VNC) images. VNC images have the potential to replace true non-contrast scans in various clinical applications. This study investigated the quantitative accuracy of VNC attenuation images considering different parameters for acquisition and reconstruction. An abdomen phantom with 7 different tissue types (different combinations of 3 base materials and 5 iodine concentrations) was scanned using a spectral detector CT (SDCT). Different phantom sizes (S, M, L), volume computed tomography dose indices (CTDIvol 10, 15, 20 mGy), kernel settings (soft, standard, sharp), and denoising levels (low, medium, high) were tested. Conventional and VNC images were reconstructed and analyzed based on regions of interest (ROI). Mean and standard deviation were recorded and differences in attenuation between corresponding base materials and VNC was calculated (VNCerror). Statistic analysis included ANOVA, Wilcoxon test and multivariate regression analysis. Overall, the VNC error was − 1.4 ± 6.1 HU. While radiation dose, kernel setting, and denoising level did not influence VNC error significantly, phantom size, iodine content and base material had a significant effect (e.g. S vs. M: − 1.2 ± 4.9 HU vs. − 2.1 ± 6.0 HU; 0.0 mg/ml vs. 5.0 mg/ml: − 4.0 ± 3.5 HU vs. 5.1 ± 5.0 HU and 35-HU-base vs. 54-HU-base: − 3.5 ± 4.4 HU vs. 0.7 ± 6.5; all p  ≤ 0.05). The overall accuracy of VNC images from SDCT is high and independent from dose, kernel, and denoising settings; however, shows a dependency on patient size, base material, and iodine content; particularly the latter results in small, yet, noticeable differences in VNC attenuation.

ObjectivesTo predict the main component of pure and mixed kidney stones using dual-energy computed tomography and machine learning.Methods200 kidney stones with a known composition as determined by infrared spectroscopy were examined using a non-anthropomorphic phantom on a spectral detector computed tomography scanner. Stones were of either pure (monocrystalline, n = 116) or compound (dicrystalline, n = 84) composition. Image acquisition was repeated twice using both, normal and low-dose protocols, respectively (ND/LD). Conventional images and low and high keV virtual monoenergetic images were reconstructed. Stones were semi-automatically segmented. A shallow neural network was trained using data from ND1 acquisition split into training (70%), testing (15%) and validation-datasets (15%). Performance for ND2 and both LD acquisitions was tested. Accuracy on a per-voxel and a per-stone basis was calculated.ResultsMain components were: Whewellite (n = 80), weddellite (n = 21), Ca-phosphate (n = 39), cysteine (n = 20), struvite (n = 13), uric acid (n = 18) and xanthine stones (n = 9). Stone size ranged from 3 to 18 mm. Overall accuracy for predicting the main component on a per-voxel basis attained by ND testing dataset was 91.1%. On independently tested acquisitions, accuracy was 87.1–90.4%.ConclusionsEven in compound stones, the main component can be reliably determined using dual energy CT and machine learning, irrespective of dose protocol.Key Points• Spectral Detector Dual Energy CT and Machine Learning allow for an accurate prediction of stone composition.• Ex-vivo study demonstrates the dose independent assessment of pure and compound stones.• Lowest accuracy is reported for compound stones with struvite as main component.

Objectives To demonstrate the feasibility of an automated, non-invasive approach to estimate bone marrow (BM) infiltration of multiple myeloma (MM) by dual-energy computed tomography (DECT) after virtual non-calcium (VNCa) post-processing. Methods Individuals with MM and monoclonal gammopathy of unknown significance (MGUS) with concurrent DECT and BM biopsy between May 2018 and July 2020 were included in this retrospective observational study. Two pathologists and three radiologists reported BM infiltration and presence of osteolytic bone lesions, respectively. Bone mineral density (BMD) was quantified CT-based by a CE-certified software. Automated spine segmentation was implemented by a pre-trained convolutional neural network. The non-fatty portion of BM was defined as voxels > 0 HU in VNCa. For statistical assessment, multivariate regression and receiver operating characteristic (ROC) were conducted. Results Thirty-five patients (mean age 65 ± 12 years; 18 female) were evaluated. The non-fatty portion of BM significantly predicted BM infiltration after adjusting for the covariable BMD ( p  = 0.007, r  = 0.46). A non-fatty portion of BM > 0.93% could anticipate osteolytic lesions and the clinical diagnosis of MM with an area under the ROC curve of 0.70 [0.49–0.90] and 0.71 [0.54–0.89], respectively. Our approach identified MM-patients without osteolytic lesions on conventional CT with a sensitivity and specificity of 0.63 and 0.71, respectively. Conclusions Automated, AI-supported attenuation assessment of the spine in DECT VNCa is feasible to predict BM infiltration in MM. Further, the proposed method might allow for pre-selecting patients with higher pre-test probability of osteolytic bone lesions and support the clinical diagnosis of MM without pathognomonic lesions on conventional CT. Key Points • The retrospective study provides an automated approach for quantification of the non-fatty portion of bone marrow, based on AI-supported spine segmentation and virtual non-calcium dual-energy CT data. • An increasing non-fatty portion of bone marrow is associated with a higher infiltration determined by invasive biopsy after adjusting for bone mineral density as a control variable (p  =  0.007, r  =  0.46). • The non-fatty portion of bone marrow might support the clinical diagnosis of multiple myeloma when conventional CT images are negative (sensitivity 0.63, specificity 0.71).